BullFrog AI Holdings BFRGW
NASDAQ BFRGW
$0.10 0.00 (-3.75%)
As of: Sep 9, 2026 · 11:58 AM EDT

BullFrog AI Holdings (BFRGW) Convertible Debt (2022)

BullFrog AI Holdings' (BFRGW) quarterly Convertible Debt came in at $1.0 million in Q4 2022.

Analysis

BullFrog AI Holdings (BFRGW) Convertible Debt (2022) Analysis & Trends

BullFrog AI Holdings (BFRGW) has reported Convertible Debt for 1 consecutive years, with $1.0 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Convertible Debt changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2022 stood at $1.0 million (changed N/A YoY), and the FY2022 full-year result was $1.0 million, changed N/A from the prior year.
  • Convertible Debt steadied at $1.0 million in Q4 2022 per BFRGW's latest filing.
  • Across five years, Convertible Debt topped out at $1.0 million in Q4 2022 and bottomed at $1.0 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.86 Bn 196.87 Bn 7.24 Bn
2 Gilead Sciences 181.23 Bn 178.05 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.14 Bn 124.29 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.88 Bn 74.88 Bn 3.93 Bn
5 Argenx Se 61.72 Bn 56.54 Bn 1.37 Bn
6 Moderna 54.82 Bn 49.68 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.09 Bn 30.79 Bn 992.69 Mn
8 Biogen 31.28 Bn 29.99 Bn 1.96 Bn
9 Roivant Sciences 30.40 Bn 30.40 Bn 1.16 Mn
10 BullFrog AI Holdings 1.84 Mn -5.08 Mn 106,899.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.02 Mn